PharmaCyte Biotech Inc (PMCB)

[jedijazz]

PMCB Overview from Newly Filed FORM 10-Q PharmaCyte Biotech, Inc. (PMCB) | Quarterly Report
Mar. 19, 2018 4:37 PM|About: PharmaCyte Biotech, Inc. (PMCB)



We are a clinical stage biotechnology company focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box ® .” The Cell-in-a-Box® technology is intended to be used as a platform upon which therapies for several types of cancer, including locally advanced, non-metastatic inoperable pancreatic cancer, and diabetes will be developed.



We are developing therapies for pancreatic and other solid cancerous tumors by using the encapsulation of live cells which are surgically implanted at appropriate sites in the body to enable the delivery of a cancer-killing chemotherapy drug at the source of the cancer. We are working on our IND to submit to the United States Food and Drug Administration (“FDA”) so that we can commence a clinical trial involving locally advanced, inoperable non-metastatic pancreatic cancer. Based on advice from our consulting oncologists, our Chief Medical Officer and our Advisory Board regarding our planned trial design, we have determined that the data contained in previous clinical trial reports are not enough to fully support a Phase 3 pivotal trial. Therefore, we are designing a Phase 2b clinical trial that, if successful, we believe will provide the information necessary for a successful Phase 3 pivotal trial and possible accelerated approval by the FDA.



We are also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes. The Company’s diabetes therapy consists of encapsulating genetically modified human cells and/or beta islet cells using the Cell-in-a-Box ® technology and then implanting them in the body to act as a bio-artificial pancreas for insulin production.



In addition, we are examining ways to exploit the benefits of the Cell-in-a-Box ® technology to develop therapies for cancer based upon the constituents of the Cannabis plant, known as “Cannabinoids.”

Download Report here: https://seekingalpha.com/filings/pdf/12634598.pdf